Interview with Meridian’s Milton Boyer

Key Learning Objectives:

• The merger of Kindeva Drug Delivery and Meridian Medical Technologies creates a leading CDMO with robust drug-device capabilities.
• The merged organization offers expansive end-to-end services for government and private entities with support from 9 R&D facilities.
• The new Kindeva better meets an expansive array of client needs with enhanced development and manufacturing capabilities for life-changing therapies and high-quality products.